Related Experiment Video
Updated: Oct 25, 2025

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies
Luke Schenck1, Christopher Boyce2, Derek Frank1
1Process Research & Development, Merck & Co., Inc., Kenilworth, NJ 07033, USA.
Co-precipitation offers a streamlined method for creating amorphous solid dispersions (ASDs) suitable for safety studies. This approach yields materials with properties comparable to those produced by spray drying, addressing limitations of the latter.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
Background:
- Amorphous solid dispersions (ASDs) enhance drug solubility and bioavailability.
- Spray drying is a common method for ASD production but has limitations like processing challenges and batch variability.
- Co-precipitation offers an alternative route to ASDs with potential advantages.
Purpose of the Study:
- To develop a streamlined co-precipitation process for generating amorphous solid dispersions (ASDs) for early safety studies.
- To create composite particles incorporating co-precipitated amorphous dispersions (cPADs) for improved re-dispersibility.
- To compare the properties and performance of cPADs with spray-dried ASDs.
Main Methods:
- Utilized co-precipitation to generate amorphous solid dispersions (ASDs).
- Developed a hierarchical particle approach to create composite particles with water-soluble excipients.
- Evaluated stability, thermal properties, and in vivo pharmacokinetics of the cPADs.
Main Results:
- Achieved a rapid, safely contained co-precipitation process with high recovery yields.
- Generated composite particles demonstrating rapid re-dispersibility for uniform suspension.
- Demonstrated that cPADs exhibit comparable stability, thermal properties, and in vivo pharmacokinetics to spray-dried ASDs.
Conclusions:
- Co-precipitation is a viable and effective method for producing amorphous solid dispersions (ASDs) for pharmaceutical applications.
- The developed hierarchical particle approach enhances the utility of cPADs in safety studies.
- Co-precipitation presents a promising alternative to spray drying for ASD manufacturing, overcoming several limitations.
Related Concept Videos
Colloidal precipitates
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Precipitate Formation and Particle Size Control
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Precipitation Processes
Colloids and Suspensions

